CCNL1_HUMAN - dbPTM
CCNL1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CCNL1_HUMAN
UniProt AC Q9UK58
Protein Name Cyclin-L1
Gene Name CCNL1
Organism Homo sapiens (Human).
Sequence Length 526
Subcellular Localization Nucleus speckle . Nucleus, nucleoplasm . Found in nuclear intrachromatin granules clusters (IGC), also called nuclear speckles, which are storage compartments for nuclear proteins involved in mRNA processing..
Protein Description Involved in pre-mRNA splicing. Functions in association with cyclin-dependent kinases (CDKs). [PubMed: 18216018 Inhibited by the CDK-specific inhibitor CDKN1A/p21]
Protein Sequence MASGPHSTATAAAAASSAAPSAGGSSSGTTTTTTTTTGGILIGDRLYSEVSLTIDHSLIPEERLSPTPSMQDGLDLPSETDLRILGCELIQAAGILLRLPQVAMATGQVLFHRFFYSKSFVKHSFEIVAMACINLASKIEEAPRRIRDVINVFHHLRQLRGKRTPSPLILDQNYINTKNQVIKAERRVLKELGFCVHVKHPHKIIVMYLQVLECERNQTLVQTAWNYMNDSLRTNVFVRFQPETIACACIYLAARALQIPLPTRPHWFLLFGTTEEEIQEICIETLRLYTRKKPNYELLEKEVEKRKVALQEAKLKAKGLNPDGTPALSTLGGFSPASKPSSPREVKAEEKSPISINVKTVKKEPEDRQQASKSPYNGVRKDSKRSRNSRSASRSRSRTRSRSRSHTPRRHYNNRRSRSGTYSSRSRSRSRSHSESPRRHHNHGSPHLKAKHTRDDLKSSNRHGHKRKKSRSRSQSKSRDHSDAAKKHRHERGHHRDRRERSRSFERSHKSKHHGGSRSGHGRHRR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
30PhosphorylationGGSSSGTTTTTTTTT
CCCCCCCEEEEEEEC
26.18-
32PhosphorylationSSSGTTTTTTTTTGG
CCCCCEEEEEEECCC
21.76-
33PhosphorylationSSGTTTTTTTTTGGI
CCCCEEEEEEECCCE
21.76-
37PhosphorylationTTTTTTTTGGILIGD
EEEEEEECCCEEECC
31.17-
47PhosphorylationILIGDRLYSEVSLTI
EEECCCCEEEEEEEE
12.0428122231
48PhosphorylationLIGDRLYSEVSLTID
EECCCCEEEEEEEEC
35.7928122231
51PhosphorylationDRLYSEVSLTIDHSL
CCCEEEEEEEECCCC
18.7528122231
53PhosphorylationLYSEVSLTIDHSLIP
CEEEEEEEECCCCCC
19.4928122231
57PhosphorylationVSLTIDHSLIPEERL
EEEEECCCCCCHHHC
25.0128122231
65PhosphorylationLIPEERLSPTPSMQD
CCCHHHCCCCCCCCC
32.7129255136
67PhosphorylationPEERLSPTPSMQDGL
CHHHCCCCCCCCCCC
25.3129255136
69PhosphorylationERLSPTPSMQDGLDL
HHCCCCCCCCCCCCC
31.3929255136
164PhosphorylationRQLRGKRTPSPLILD
HHHCCCCCCCCEEEC
31.4428450419
166PhosphorylationLRGKRTPSPLILDQN
HCCCCCCCCEEECCC
31.5528464451
178UbiquitinationDQNYINTKNQVIKAE
CCCCCCCHHHHHHHH
40.6829967540
183AcetylationNTKNQVIKAERRVLK
CCHHHHHHHHHHHHH
45.3925953088
289PhosphorylationCIETLRLYTRKKPNY
HHHHHHHHCCCCCCH
9.69-
314AcetylationKVALQEAKLKAKGLN
HHHHHHHHHHHCCCC
50.1725953088
325PhosphorylationKGLNPDGTPALSTLG
CCCCCCCCCCHHHCC
16.8729255136
329PhosphorylationPDGTPALSTLGGFSP
CCCCCCHHHCCCCCC
24.5629255136
330PhosphorylationDGTPALSTLGGFSPA
CCCCCHHHCCCCCCC
30.2129255136
335PhosphorylationLSTLGGFSPASKPSS
HHHCCCCCCCCCCCC
23.8829255136
338PhosphorylationLGGFSPASKPSSPRE
CCCCCCCCCCCCCCC
48.7829255136
339SumoylationGGFSPASKPSSPREV
CCCCCCCCCCCCCCC
51.5328112733
341PhosphorylationFSPASKPSSPREVKA
CCCCCCCCCCCCCCC
57.6322167270
342PhosphorylationSPASKPSSPREVKAE
CCCCCCCCCCCCCCC
36.1822167270
347SumoylationPSSPREVKAEEKSPI
CCCCCCCCCCCCCCC
45.3828112733
352PhosphorylationEVKAEEKSPISINVK
CCCCCCCCCCEEEEE
30.6429255136
355PhosphorylationAEEKSPISINVKTVK
CCCCCCCEEEEEEEC
16.1122167270
359AcetylationSPISINVKTVKKEPE
CCCEEEEEEECCCHH
43.0125953088
362SumoylationSINVKTVKKEPEDRQ
EEEEEEECCCHHHHH
57.5625755297
372PhosphorylationPEDRQQASKSPYNGV
HHHHHHHCCCCCCCC
29.3623401153
374PhosphorylationDRQQASKSPYNGVRK
HHHHHCCCCCCCCCC
30.0723401153
376PhosphorylationQQASKSPYNGVRKDS
HHHCCCCCCCCCCCC
31.4730266825
401PhosphorylationRSRSRTRSRSRSHTP
HHHHHHHHHCCCCCC
33.7119651622
403PhosphorylationRSRTRSRSRSHTPRR
HHHHHHHCCCCCCCC
39.1119651622
405PhosphorylationRTRSRSRSHTPRRHY
HHHHHCCCCCCCCCC
32.7219651622
407PhosphorylationRSRSRSHTPRRHYNN
HHHCCCCCCCCCCCC
21.5325599653
417PhosphorylationRHYNNRRSRSGTYSS
CCCCCCCCCCCCCCC
27.79-
419PhosphorylationYNNRRSRSGTYSSRS
CCCCCCCCCCCCCCC
36.41-
421PhosphorylationNRRSRSGTYSSRSRS
CCCCCCCCCCCCCCC
22.83-
422PhosphorylationRRSRSGTYSSRSRSR
CCCCCCCCCCCCCCC
14.2621406692
423PhosphorylationRSRSGTYSSRSRSRS
CCCCCCCCCCCCCCC
21.0721406692
424PhosphorylationSRSGTYSSRSRSRSR
CCCCCCCCCCCCCCC
24.7021406692
426PhosphorylationSGTYSSRSRSRSRSH
CCCCCCCCCCCCCCC
36.2321406692
430PhosphorylationSSRSRSRSRSHSESP
CCCCCCCCCCCCCCC
39.1124719451
432PhosphorylationRSRSRSRSHSESPRR
CCCCCCCCCCCCCCC
32.3930177828
434PhosphorylationRSRSRSHSESPRRHH
CCCCCCCCCCCCCCC
40.8030177828
436PhosphorylationRSRSHSESPRRHHNH
CCCCCCCCCCCCCCC
27.0724719451
445PhosphorylationRRHHNHGSPHLKAKH
CCCCCCCCCCHHCCC
11.1227362937
449AcetylationNHGSPHLKAKHTRDD
CCCCCCHHCCCCHHH
52.977427899
451AcetylationGSPHLKAKHTRDDLK
CCCCHHCCCCHHHHH
43.877427909
470PhosphorylationHGHKRKKSRSRSQSK
HHCCHHHHHCHHHHH
38.22-
471MethylationGHKRKKSRSRSQSKS
HCCHHHHHCHHHHHC
44.99-
473MethylationKRKKSRSRSQSKSRD
CHHHHHCHHHHHCCC
37.29-
486UbiquitinationRDHSDAAKKHRHERG
CCCHHHHHHHHHHHH
51.32-
487UbiquitinationDHSDAAKKHRHERGH
CCHHHHHHHHHHHHC
40.94-
502PhosphorylationHRDRRERSRSFERSH
HHHHHHHHHHHHHHH
27.7628355574
504PhosphorylationDRRERSRSFERSHKS
HHHHHHHHHHHHHCC
32.4828355574
512MethylationFERSHKSKHHGGSRS
HHHHHCCCCCCCCCC
44.41-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CCNL1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CCNL1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CCNL1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CD11A_HUMANCDK11Aphysical
11980906
CD11A_HUMANCDK11Aphysical
11683997
A4_HUMANAPPphysical
21832049
JMJD6_HUMANJMJD6physical
23455924

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CCNL1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335; SER-338; SER-352AND SER-355, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-325; SER-329; SER-335;SER-338; SER-341 AND SER-342, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-325; SER-335; SER-338;SER-342; SER-352 AND SER-355, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65 AND SER-355, AND MASSSPECTROMETRY.

TOP